[Antitumor activity of platinum analogs against human ovarian tumors heterotransplanted into nude mice]. 1987

M Sawada, and M Ozaki, and J Hongo, and Y Hirota, and M Inagaki, and H Taniguchi, and R Tateishi, and Y Mori

The chemotherapeutic effects of CDDP, CBDCA and CHIP on human ovarian cancers heterotransplanted into nude mice (mucinous cystadenocarcinoma OVA-1, poorly differentiated adenocarcinoma OVA-2, endometrioid adenocarcinoma OVA-3, serous cystadenocarcinoma OVA-4, and three yolk sac tumors YST-1, YST-2, YST-3) were examined. OVA-1 did not respond to CDDP, although it responded well to CBDCA and CHIP. OVA-2 responded well to all these platinum analogs. OVA-3 responded well to CDDP, but did not respond to CBDCA or CHIP. OVA-4 responded well to CDDP and CBDCA, but did not respond to CHIP. Tumors YST-2 and YST-3 exhibited broadly comparable sensitivity to CDDP and the two other analogs, and YST-1 was substantially more sensitive to CDDP than to CBDCA or CHIP. The results indicated the necessity of selection of platinum analogs according to the histological types of tumor for the effective treatment of ovarian cancer.

UI MeSH Term Description Entries
D008819 Mice, Nude Mutant mice homozygous for the recessive gene "nude" which fail to develop a thymus. They are useful in tumor studies and studies on immune responses. Athymic Mice,Mice, Athymic,Nude Mice,Mouse, Athymic,Mouse, Nude,Athymic Mouse,Nude Mouse
D009368 Neoplasm Transplantation Experimental transplantation of neoplasms in laboratory animals for research purposes. Transplantation, Neoplasm,Neoplasm Transplantations,Transplantations, Neoplasm
D009944 Organoplatinum Compounds Organic compounds which contain platinum as an integral part of the molecule. Compounds, Organoplatinum
D010051 Ovarian Neoplasms Tumors or cancer of the OVARY. These neoplasms can be benign or malignant. They are classified according to the tissue of origin, such as the surface EPITHELIUM, the stromal endocrine cells, and the totipotent GERM CELLS. Cancer of Ovary,Ovarian Cancer,Cancer of the Ovary,Neoplasms, Ovarian,Ovary Cancer,Ovary Neoplasms,Cancer, Ovarian,Cancer, Ovary,Cancers, Ovarian,Cancers, Ovary,Neoplasm, Ovarian,Neoplasm, Ovary,Neoplasms, Ovary,Ovarian Cancers,Ovarian Neoplasm,Ovary Cancers,Ovary Neoplasm
D001835 Body Weight The mass or quantity of heaviness of an individual. It is expressed by units of pounds or kilograms. Body Weights,Weight, Body,Weights, Body
D002945 Cisplatin An inorganic and water-soluble platinum complex. After undergoing hydrolysis, it reacts with DNA to produce both intra and interstrand crosslinks. These crosslinks appear to impair replication and transcription of DNA. The cytotoxicity of cisplatin correlates with cellular arrest in the G2 phase of the cell cycle. Platinum Diamminodichloride,cis-Diamminedichloroplatinum(II),cis-Dichlorodiammineplatinum(II),Biocisplatinum,Dichlorodiammineplatinum,NSC-119875,Platidiam,Platino,Platinol,cis-Diamminedichloroplatinum,cis-Platinum,Diamminodichloride, Platinum,cis Diamminedichloroplatinum,cis Platinum
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D000970 Antineoplastic Agents Substances that inhibit or prevent the proliferation of NEOPLASMS. Anticancer Agent,Antineoplastic,Antineoplastic Agent,Antineoplastic Drug,Antitumor Agent,Antitumor Drug,Cancer Chemotherapy Agent,Cancer Chemotherapy Drug,Anticancer Agents,Antineoplastic Drugs,Antineoplastics,Antitumor Agents,Antitumor Drugs,Cancer Chemotherapy Agents,Cancer Chemotherapy Drugs,Chemotherapeutic Anticancer Agents,Chemotherapeutic Anticancer Drug,Agent, Anticancer,Agent, Antineoplastic,Agent, Antitumor,Agent, Cancer Chemotherapy,Agents, Anticancer,Agents, Antineoplastic,Agents, Antitumor,Agents, Cancer Chemotherapy,Agents, Chemotherapeutic Anticancer,Chemotherapy Agent, Cancer,Chemotherapy Agents, Cancer,Chemotherapy Drug, Cancer,Chemotherapy Drugs, Cancer,Drug, Antineoplastic,Drug, Antitumor,Drug, Cancer Chemotherapy,Drug, Chemotherapeutic Anticancer,Drugs, Antineoplastic,Drugs, Antitumor,Drugs, Cancer Chemotherapy

Related Publications

M Sawada, and M Ozaki, and J Hongo, and Y Hirota, and M Inagaki, and H Taniguchi, and R Tateishi, and Y Mori
September 1982, Nihon Sanka Fujinka Gakkai zasshi,
M Sawada, and M Ozaki, and J Hongo, and Y Hirota, and M Inagaki, and H Taniguchi, and R Tateishi, and Y Mori
November 1988, Nihon Sanka Fujinka Gakkai zasshi,
M Sawada, and M Ozaki, and J Hongo, and Y Hirota, and M Inagaki, and H Taniguchi, and R Tateishi, and Y Mori
February 1988, Nihon Hinyokika Gakkai zasshi. The japanese journal of urology,
M Sawada, and M Ozaki, and J Hongo, and Y Hirota, and M Inagaki, and H Taniguchi, and R Tateishi, and Y Mori
August 1984, International journal of cancer,
M Sawada, and M Ozaki, and J Hongo, and Y Hirota, and M Inagaki, and H Taniguchi, and R Tateishi, and Y Mori
March 1986, British journal of cancer,
M Sawada, and M Ozaki, and J Hongo, and Y Hirota, and M Inagaki, and H Taniguchi, and R Tateishi, and Y Mori
January 1978, Acta obstetricia et gynecologica Scandinavica,
M Sawada, and M Ozaki, and J Hongo, and Y Hirota, and M Inagaki, and H Taniguchi, and R Tateishi, and Y Mori
November 1990, Japanese journal of cancer research : Gann,
M Sawada, and M Ozaki, and J Hongo, and Y Hirota, and M Inagaki, and H Taniguchi, and R Tateishi, and Y Mori
January 1983, Experimental cell biology,
M Sawada, and M Ozaki, and J Hongo, and Y Hirota, and M Inagaki, and H Taniguchi, and R Tateishi, and Y Mori
May 1977, Journal of the National Cancer Institute,
M Sawada, and M Ozaki, and J Hongo, and Y Hirota, and M Inagaki, and H Taniguchi, and R Tateishi, and Y Mori
February 1990, International journal of cancer,
Copied contents to your clipboard!